Literature DB >> 27293862

Localized malignant pleural sarcomatoid mesothelioma misdiagnosed as benign localized fibrous tumor.

Kwan-Chang Kim1, Hong-Phuc Vo1.   

Abstract

Localized malignant pleural mesothelioma (LMPM) is a rare tumor with good prognosis by surgical resection. We report an atypical case of malignant pleural sarcomatoid mesothelioma (SM) in an asymptomatic 65-year-old woman, who had no history of exposure to asbestos. She presented with a small pleural mass without pleural effusion and was misdiagnosed as a benign localized fibrous tumor (BLFT) on pathologic examination through a surgical tumor specimen. However, seven months later, the patient returned with serious cancerous symptoms. A large recurrent tumor mass was found within the chest wall invading at the old surgical resection site. SM, a subtype of LMPM, was confirmed with histopathogy and immunohistochemisty. In conclusion, malignant pleural mesothelioma (MPM) can present with typical radiologic finding similar to a BLFT, and has a wide histopathologic presentation in biopsy specimen. A thorough pathologic investigation should be attempted even when a pleural mass resembles benign, localized, and small on radiologic studies.

Entities:  

Keywords:  Pleura; computed tomography (CT); lobectomy; mesothelioma; pathology

Year:  2016        PMID: 27293862      PMCID: PMC4885954          DOI: 10.21037/jtd.2016.03.92

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  36 in total

Review 1.  Localized fibrous tumours of the pleura: 15 new cases and review of the literature.

Authors:  M Suter; S Gebhard; M Boumghar; N Peloponisios; C Y Genton
Journal:  Eur J Cardiothorac Surg       Date:  1998-11       Impact factor: 4.191

Review 2.  Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy.

Authors:  K B Allen; L P Faber; W H Warren
Journal:  Chest Surg Clin N Am       Date:  1994-02

3.  Malignant pleural mesothelioma: CT manifestations in 50 cases.

Authors:  A Kawashima; H I Libshitz
Journal:  AJR Am J Roentgenol       Date:  1990-11       Impact factor: 3.959

Review 4.  Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.

Authors:  Zhen J Wang; Gautham P Reddy; Michael B Gotway; Charles B Higgins; David M Jablons; Mohan Ramaswamy; Randall A Hawkins; W Richard Webb
Journal:  Radiographics       Date:  2004 Jan-Feb       Impact factor: 5.333

Review 5.  [Malignant pleural mesothelioma: comparison of radical pleurectomy und extrapleural pneumonectomy].

Authors:  S Bölükbas; J Schirren
Journal:  Chirurg       Date:  2013-06       Impact factor: 0.955

6.  Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

Authors:  Aliya N Husain; Thomas Colby; Nelson Ordonez; Thomas Krausz; Richard Attanoos; Mary Beth Beasley; Alain C Borczuk; Kelly Butnor; Philip T Cagle; Lucian R Chirieac; Andrew Churg; Sanja Dacic; Armando Fraire; Francoise Galateau-Salle; Allen Gibbs; Allen Gown; Samuel Hammar; Leslie Litzky; Alberto M Marchevsky; Andrew G Nicholson; Victor Roggli; William D Travis; Mark Wick
Journal:  Arch Pathol Lab Med       Date:  2012-08-28       Impact factor: 5.534

Review 7.  Localized malignant mesothelioma. A clinicopathologic and flow cytometric study.

Authors:  T B Crotty; J L Myers; A L Katzenstein; H D Tazelaar; S J Swensen; A Churg
Journal:  Am J Surg Pathol       Date:  1994-04       Impact factor: 6.394

8.  Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial.

Authors:  Luana Calabrò; Aldo Morra; Ester Fonsatti; Ornella Cutaia; Giovanni Amato; Diana Giannarelli; Anna Maria Di Giacomo; Riccardo Danielli; Maresa Altomonte; Luciano Mutti; Michele Maio
Journal:  Lancet Oncol       Date:  2013-09-11       Impact factor: 41.316

9.  The Mesothelioma epidemic in Western Europe: an update.

Authors:  C Pelucchi; M Malvezzi; C La Vecchia; F Levi; A Decarli; E Negri
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

10.  Phrenic nerve paralysis as the initial presentation in pleural sarcomatoid mesothelioma.

Authors:  Go Makimoto; Keiichi Fujiwara; Nobukazu Fujimoto; Ichiro Yamadori; Toshio Sato; Takumi Kishimoto
Journal:  Case Rep Oncol       Date:  2014-06-14
View more
  5 in total

Review 1.  Clinical diagnosis of malignant pleural mesothelioma.

Authors:  Andrea Bianco; Tullio Valente; Maria Luisa De Rimini; Giacomo Sica; Alfonso Fiorelli
Journal:  J Thorac Dis       Date:  2018-01       Impact factor: 2.895

Review 2.  Localized malignant mesothelioma, an unusual and poorly characterized neoplasm of serosal origin: best current evidence from the literature and the International Mesothelioma Panel.

Authors:  Alberto M Marchevsky; Andras Khoor; Ann E Walts; Andrew G Nicholson; Yu Zhi Zhang; Victor Roggli; John Carney; Anja C Roden; Henry D Tazelaar; Brandon T Larsen; Nolwenn LeStang; Lucian R Chirieac; Sonja Klebe; Ming-Sound Tsao; Marc De Perrot; Andrew Pierre; David M Hwang; Yin P Hung; Mari Mino-Kenudson; William Travis; Jennifer Sauter; Mary Beth Beasley; Françoise Galateau-Sallé
Journal:  Mod Pathol       Date:  2019-09-04       Impact factor: 7.842

3.  Localized malignant pleural mesothelioma mimicking an anterior mediastinal tumor.

Authors:  Takuya Hino; Takeshi Kamitani; Koji Sagiyama; Yuzo Yamasaki; Isamu Okamoto; Tetsuzo Tagawa; Kayo Ijichi; Hidetaka Yamamoto; Hidetake Yabuuchi; Hiroshi Honda
Journal:  Eur J Radiol Open       Date:  2019-01-31

4.  Multiple intracranial metastases from postoperative giant sarcomatoid malignant pleural mesothelioma: A case report and literature review.

Authors:  Dong Tian; Hongying Wen; Ham Ebo Brown; Xianzhi Wang; Lin Zhang; Maoyong Fu
Journal:  Mol Clin Oncol       Date:  2017-11-08

5.  Malignant Pleural Mesothelioma, Biphasic Type: An Unusual and Insidious Case of Rapidly Progressive Small Blue Cell Tumor.

Authors:  Carlos Salazar; Nelson Kanter Md; Amer Abboud
Journal:  Cureus       Date:  2018-06-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.